Actin-binding protein, espin

A novel metastatic regulator for melanoma

Takeshi Yanagishita, Ichiro Yajima, Mayuko Kumasaka, Yoshiyuki Kawamoto, Toyonori Tsuzuki, Yoshinari Matsumoto, Daisuke Watanabe, Masashi Kato

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Espin is a multifunctional actin-bundling protein with multiple isoforms, and has special connections to hair cell stereocilia and microvillar specializations of sensory cells in the inner ear. However, there have been no reports showing the expression and function of Espin in cancers, including melanoma. Here, it is demonstrated that Espin expression is significantly increased in melanomas that spontaneously developed in RET-transgenic mice (RET-mice). Importantly, the invasion capacity of Espin-depleted Mel-ret melanoma cells derived from a tumor of the RET-mouse was dramatically less than that of control melanoma cells with reductions of lamellipodia, focal adhesion kinase (FAK), and GTP-Rac1 activities. Correspondingly, the ratio of metastatic foci in Espin-depleted Mel-ret melanoma cells was significantly less than that of control melanoma cells in an in vivo melanoma metastasis model. Moreover, Espin could be a novel biomarker of melanoma in humans, because our immunohistochemical analysis data reveal that percentages of Espin-positive cells in human primary and metastatic melanomas were significantly higher than that of cells in melanocytic nevi. Together, these results indicate that Espin is not only a metastatic regulator for melanoma but also a potential biomarker of disease progression. Implications: Actin-binding protein Espin is expressed in melanoma, affects metastasis, and is a potential target for melanoma therapy.

Original languageEnglish
Pages (from-to)440-446
Number of pages7
JournalMolecular Cancer Research
Volume12
Issue number3
DOIs
Publication statusPublished - 2014 Jan 1
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Biology
  • Oncology
  • Cancer Research

Cite this

Yanagishita, T., Yajima, I., Kumasaka, M., Kawamoto, Y., Tsuzuki, T., Matsumoto, Y., ... Kato, M. (2014). Actin-binding protein, espin: A novel metastatic regulator for melanoma. Molecular Cancer Research, 12(3), 440-446. https://doi.org/10.1158/1541-7786.MCR-13-0468-T

Actin-binding protein, espin : A novel metastatic regulator for melanoma. / Yanagishita, Takeshi; Yajima, Ichiro; Kumasaka, Mayuko; Kawamoto, Yoshiyuki; Tsuzuki, Toyonori; Matsumoto, Yoshinari; Watanabe, Daisuke; Kato, Masashi.

In: Molecular Cancer Research, Vol. 12, No. 3, 01.01.2014, p. 440-446.

Research output: Contribution to journalArticle

Yanagishita, T, Yajima, I, Kumasaka, M, Kawamoto, Y, Tsuzuki, T, Matsumoto, Y, Watanabe, D & Kato, M 2014, 'Actin-binding protein, espin: A novel metastatic regulator for melanoma', Molecular Cancer Research, vol. 12, no. 3, pp. 440-446. https://doi.org/10.1158/1541-7786.MCR-13-0468-T
Yanagishita, Takeshi ; Yajima, Ichiro ; Kumasaka, Mayuko ; Kawamoto, Yoshiyuki ; Tsuzuki, Toyonori ; Matsumoto, Yoshinari ; Watanabe, Daisuke ; Kato, Masashi. / Actin-binding protein, espin : A novel metastatic regulator for melanoma. In: Molecular Cancer Research. 2014 ; Vol. 12, No. 3. pp. 440-446.
@article{de4503a530b447f3bfac2a241a0db849,
title = "Actin-binding protein, espin: A novel metastatic regulator for melanoma",
abstract = "Espin is a multifunctional actin-bundling protein with multiple isoforms, and has special connections to hair cell stereocilia and microvillar specializations of sensory cells in the inner ear. However, there have been no reports showing the expression and function of Espin in cancers, including melanoma. Here, it is demonstrated that Espin expression is significantly increased in melanomas that spontaneously developed in RET-transgenic mice (RET-mice). Importantly, the invasion capacity of Espin-depleted Mel-ret melanoma cells derived from a tumor of the RET-mouse was dramatically less than that of control melanoma cells with reductions of lamellipodia, focal adhesion kinase (FAK), and GTP-Rac1 activities. Correspondingly, the ratio of metastatic foci in Espin-depleted Mel-ret melanoma cells was significantly less than that of control melanoma cells in an in vivo melanoma metastasis model. Moreover, Espin could be a novel biomarker of melanoma in humans, because our immunohistochemical analysis data reveal that percentages of Espin-positive cells in human primary and metastatic melanomas were significantly higher than that of cells in melanocytic nevi. Together, these results indicate that Espin is not only a metastatic regulator for melanoma but also a potential biomarker of disease progression. Implications: Actin-binding protein Espin is expressed in melanoma, affects metastasis, and is a potential target for melanoma therapy.",
author = "Takeshi Yanagishita and Ichiro Yajima and Mayuko Kumasaka and Yoshiyuki Kawamoto and Toyonori Tsuzuki and Yoshinari Matsumoto and Daisuke Watanabe and Masashi Kato",
year = "2014",
month = "1",
day = "1",
doi = "10.1158/1541-7786.MCR-13-0468-T",
language = "English",
volume = "12",
pages = "440--446",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Actin-binding protein, espin

T2 - A novel metastatic regulator for melanoma

AU - Yanagishita, Takeshi

AU - Yajima, Ichiro

AU - Kumasaka, Mayuko

AU - Kawamoto, Yoshiyuki

AU - Tsuzuki, Toyonori

AU - Matsumoto, Yoshinari

AU - Watanabe, Daisuke

AU - Kato, Masashi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Espin is a multifunctional actin-bundling protein with multiple isoforms, and has special connections to hair cell stereocilia and microvillar specializations of sensory cells in the inner ear. However, there have been no reports showing the expression and function of Espin in cancers, including melanoma. Here, it is demonstrated that Espin expression is significantly increased in melanomas that spontaneously developed in RET-transgenic mice (RET-mice). Importantly, the invasion capacity of Espin-depleted Mel-ret melanoma cells derived from a tumor of the RET-mouse was dramatically less than that of control melanoma cells with reductions of lamellipodia, focal adhesion kinase (FAK), and GTP-Rac1 activities. Correspondingly, the ratio of metastatic foci in Espin-depleted Mel-ret melanoma cells was significantly less than that of control melanoma cells in an in vivo melanoma metastasis model. Moreover, Espin could be a novel biomarker of melanoma in humans, because our immunohistochemical analysis data reveal that percentages of Espin-positive cells in human primary and metastatic melanomas were significantly higher than that of cells in melanocytic nevi. Together, these results indicate that Espin is not only a metastatic regulator for melanoma but also a potential biomarker of disease progression. Implications: Actin-binding protein Espin is expressed in melanoma, affects metastasis, and is a potential target for melanoma therapy.

AB - Espin is a multifunctional actin-bundling protein with multiple isoforms, and has special connections to hair cell stereocilia and microvillar specializations of sensory cells in the inner ear. However, there have been no reports showing the expression and function of Espin in cancers, including melanoma. Here, it is demonstrated that Espin expression is significantly increased in melanomas that spontaneously developed in RET-transgenic mice (RET-mice). Importantly, the invasion capacity of Espin-depleted Mel-ret melanoma cells derived from a tumor of the RET-mouse was dramatically less than that of control melanoma cells with reductions of lamellipodia, focal adhesion kinase (FAK), and GTP-Rac1 activities. Correspondingly, the ratio of metastatic foci in Espin-depleted Mel-ret melanoma cells was significantly less than that of control melanoma cells in an in vivo melanoma metastasis model. Moreover, Espin could be a novel biomarker of melanoma in humans, because our immunohistochemical analysis data reveal that percentages of Espin-positive cells in human primary and metastatic melanomas were significantly higher than that of cells in melanocytic nevi. Together, these results indicate that Espin is not only a metastatic regulator for melanoma but also a potential biomarker of disease progression. Implications: Actin-binding protein Espin is expressed in melanoma, affects metastasis, and is a potential target for melanoma therapy.

UR - http://www.scopus.com/inward/record.url?scp=84897082653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897082653&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-13-0468-T

DO - 10.1158/1541-7786.MCR-13-0468-T

M3 - Article

VL - 12

SP - 440

EP - 446

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 3

ER -